Elsevier

Experimental Cell Research

Volume 259, Issue 1, 25 August 2000, Pages 127-139
Experimental Cell Research

Regular Article
Involvement of EAT/mcl-1, an Anti-apoptotic bcl-2-Related Gene, in Murine Embryogenesis and Human Development

https://doi.org/10.1006/excr.2000.4977Get rights and content

Abstract

Apoptosis plays an important regulatory role in mammalian embryogenesis and development. EAT/mcl-1 (EAT), an anti-apoptotic bcl-2-related gene, was isolated during the early differentiation of a human embryonal carcinoma cell line, an event which serves as a model of early embryogenesis. EAT is involved in apoptotic regulation and is believed to also function as an immediate-early gene. Thus it was hypothesized that EAT would be expressed during early embryogenesis and would be involved in the regulation of apoptosis during this critical period. To clarify this early expression, two antibodies to EAT were generated by use of immunizing oligopeptide (aa 37–55) and recombinant protein (aa 31–229) for use in immunohistochemistry and immunoblotting, respectively. With these antibodies, we then determined EAT expression during murine embryogenesis and in human development, using human fetal tissue of 6 to 23 gestational weeks. During murine embryogenesis, the EAT protein was found to be rapidly induced after fertilization, to peak at the 2-cell stage, to remain constant until the 8-cell stage, and then to decrease to below unfertilized egg levels in blastocysts. EAT expression patterns in early human development were found to essentially overlap those observed in adult tissues which suggest that EAT expression continues until adulthood in terminally differentiated tissues. Among tissues distinct to fetal development, EAT was detected in the mesonephric (Wolffian) duct and paramesonephric (Müllerian) duct. It is also noteworthy that prominent EAT immunoreactivity was also observed in large primary oocytes in 21-week fetal ovary, but was not detected in primordial germ cells in 23-week fetal testis. In summary, EAT expression was detected in hematopoietic, epithelial, neural, endocrine, and urogenital cells; this provides evidence that EAT, as an anti-apoptotic molecule, possibly functions to regulate apoptosis during development in these systems.

References (57)

  • C.L. Sentman et al.

    bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes

    Cell

    (1991)
  • A. Strasser et al.

    bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship

    Cell

    (1991)
  • T.J. McDonnell et al.

    bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation

    Cell

    (1989)
  • D.J. Veis et al.

    Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair

    Cell

    (1993)
  • A. Suzuki et al.

    Involvement of EAT/mcl-1, a bcl-2 related gene, in the apoptotic mechanisms underlying human placental development and maintenance

    Placenta

    (2000)
  • J.M. Abrams et al.

    Programmed cell death during drosophila embryogenesis

    Development

    (1993)
  • C. Koseki et al.

    Apoptosis in metanephric development

    J. Cell Biol.

    (1992)
  • M.C. Raff

    Social controls on cell survival and cell death

    Nature

    (1992)
  • P.E. Neiman et al.

    Induction of apoptosis during normal and neoplastic B-cell development in the bursa of fabricius

    Proc. Natl. Acad. Sci. USA

    (1991)
  • G.R. Martin

    Teratocarcinomas and mammalian embryogenesis

    Science

    (1980)
  • B. Mintz et al.

    Normal genetically mosaic mice produced from malignant teratocarcinoma cells

    Proc. Natl. Acad. Sci. USA

    (1975)
  • J. Hata et al.

    Differentiation of human germ cell tumor cells in vivo and in vitro

    Acta Histochem. Cytochem.

    (1992)
  • A. Umezawa et al.

    Induction of mcl1/EAT, Bcl-2 related gene, by retinoic acid or heat shock in the human embryonal carcinoma cells, NCR-G3

    Cell Struct. Funct.

    (1996)
  • K.M. Kozopas et al.

    MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2

    Proc. Natl. Acad. Sci. USA

    (1993)
  • J.M. Adams et al.

    The Bcl-2 protein family: Arbiters of cell survival

    Science

    (1998)
  • D.T. Chao et al.

    BCL-2 family: Regulators of cell death

    Annu. Rev. Immunol.

    (1998)
  • J.C. Reed

    Bcl-2 and the regulation of programmed cell death

    J. Cell Biol.

    (1994)
  • N. Inohara et al.

    harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L)

    EMBO J.

    (1997)
  • Cited by (14)

    • MCL-1V, a novel mouse antiapoptotic MCL-1 variant, generated by RNA splicing at a non-canonical splicing pair

      2010, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      It belongs to BCL-2 antiapoptotic family members and has four BCL-2 homology (BH) domains (BH1-4) and transmembrane (TM) domain. It is essential for hematopoietic stem cell survival, maintenance and development of B and T cells and embryogenesis, but on the other hand it is expressed abundantly in various types of cancer including leukemia/lymphoma and multiple myeloma and several non-hematopoietic cancers [2–11]. MCL-1 overexpression is also associated with cancer metastasis [7,8].

    View all citing articles on Scopus
    1

    To whom correspondence and reprint requests should be addressed at Department of Pathology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. Fax: +81-3-3353-3290. E-mail: [email protected].

    View full text